Low Self-Esteem Linked to Anxiety/Depression in SLE

This article originally appeared here.
Share this content:
Low Self-Esteem Linked to Anxiety/Depression in SLE
Low Self-Esteem Linked to Anxiety/Depression in SLE

WEDNESDAY, March 15, 2017 (HealthDay News) -- For patients with systemic lupus erythematosus (SLE), measures of psychosocial reserve capacity may be associated with depression and anxiety, according to a study published online March 6 in the International Journal of Rheumatic Diseases.

Geraldine Zamora-Racaza, M.D., from the Cedars-Sinai Medical Center in Los Angeles, and colleagues examined the correlation between reserve capacity measures and anxiety/depression among 235 patients with SLE from Southern California (SoCal) and Manila in the Philippines. Participants completed self-reported scales to assess anxiety/depression and psychosocial reserve capacity measures.

The researchers found that participants from Manila reported lower socioeconomic status than participants from SoCal. High anxiety scores were reported by 69 and 59.1 percent of participants from Manila and SoCal, respectively. Higher depression scores were seen for SoCal participants (66 versus 27 percent; P < 0.001), despite exhibiting higher scores for all reserve capacity measures (P < 0.001). Higher anxiety and depression scores were reported for participants from both groups with low self-esteem scores. Participants from SoCal who reported lower optimism, lower personal mastery, and lower social support were more anxious and depressed, while less depressive symptoms were reported for Manila participants with lower scores on these three variables.

"Reduced psychosocial reserve capacity in individuals leads to vulnerabilities that may ultimately result in greater disease burden and psychological distress," the authors write.

Abstract
Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!

Already a member?

Sign In Now »


Sign up for myCME e-newsletters


Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

FDA Approves Ocrevus to Treat Severe Form of Multiple Sclerosis

FDA Approves Ocrevus to Treat Severe Form of ...

First drug sanctioned in United States for primary progressive multiple sclerosis

Study Explores Links Between Zika, GBS, Microcephaly in Brazil

Study Explores Links Between Zika, GBS, Microcephaly in ...

Apparent resurgence of Zika virus and GBS early in 2016, but no subsequent increase in microcephaly

Inadvertent HPV Vax Doesn't Up Risk of Poor Pregnancy Outcomes

Inadvertent HPV Vax Doesn't Up Risk of Poor ...

No increased risk of major birth defect, spontaneous abortion, preterm birth, low birth weight, SGA

is free, fast, and customized just for you!

Already a member?

Sign In Now »